BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7829125)

  • 1. Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma.
    Riemann D; Göhring B; Langner J
    Immunol Lett; 1994 Sep; 42(1-2):19-23. PubMed ID: 7829125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D; Skorupski W; Kwias Z; Nowak J
    Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Dal Cin P; Van den Berghe H; Ceuppens JL
    Int J Cancer; 1997 Apr; 71(2):178-82. PubMed ID: 9139839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helper T cells infiltrating human renal cell carcinomas have the phenotype of activated memory-like T lymphocytes.
    Alexander RB; Fitzgerald EB; Mixon A; Carter CS; Jakobsen M; Cohen PA; Rosenberg SA
    J Immunother Emphasis Tumor Immunol; 1995 Jan; 17(1):39-46. PubMed ID: 7728304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
    Kehlen A; Göhring B; Langner J; Riemann D
    Clin Exp Immunol; 1998 Feb; 111(2):435-41. PubMed ID: 9486416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
    Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
    J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13.
    Riemann D; Kehlen A; Langner J
    Clin Exp Immunol; 1995 May; 100(2):277-83. PubMed ID: 7743667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
    Roussel E; Gingras MC; Grimm EA; Roth JA
    Cancer Immunol Immunother; 1995 Jul; 41(1):1-9. PubMed ID: 7641214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma.
    Kopecký O; Lukesová S; Vroblová V; Vokurková D; Morávek P; Safránek H; Hlávková D; Soucek P
    Acta Medica (Hradec Kralove); 2007; 50(3):207-12. PubMed ID: 18254275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of CD13/aminopeptidase N on synovial fluid T cells from patients with different forms of joint effusions.
    Riemann D; Schwachula A; Hentschel M; Langner J
    Immunobiology; 1993 Jan; 187(1-2):24-35. PubMed ID: 8099341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis of T lymphocytes isolated from non-small-cell lung cancer.
    Riemann D; Wenzel K; Schulz T; Hofmann S; Neef H; Lautenschläger C; Langner J
    Int Arch Allergy Immunol; 1997 Sep; 114(1):38-45. PubMed ID: 9303329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.
    Yoshino I; Yano T; Murata M; Ishida T; Sugimachi K; Kimura G; Nomoto K
    Cancer Res; 1992 Feb; 52(4):775-81. PubMed ID: 1737336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal recruitment and activation of dendritic cells within renal cell carcinoma.
    Troy AJ; Summers KL; Davidson PJ; Atkinson CH; Hart DN
    Clin Cancer Res; 1998 Mar; 4(3):585-93. PubMed ID: 9533525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
    Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
    Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Wu XX; Zeng Y; Jin XH; Kakehi Y
    Oncol Rep; 2007 Aug; 18(2):353-9. PubMed ID: 17611656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
    Lukesová S; Vroblová V; Hlávková D; Kopecký O; Vokurková D; Morávek P; Safránek H; Soucek P
    Vnitr Lek; 2008 Feb; 54(2):139-45. PubMed ID: 23687704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.